| Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients： Prognostic implications |
| |
| 引用本文： | Nikiteas NI,Tzanakis N,Gazouli M,Rallis G,Daniilidis K,Theodoropoulos G,Kostakis A,Peros G. Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients： Prognostic implications[J]. World journal of gastroenterology : WJG, 2005, 11(11): 1639-1643. DOI: 10.3748/wjg.v11.i11.1639 |
| |
| 作者姓名： | Nikiteas NI Tzanakis N Gazouli M Rallis G Daniilidis K Theodoropoulos G Kostakis A Peros G |
| |
| 摘 要： | AIM: The significance of preoperative serum IL-6, TNFα and CRP levels in the progression of colorectal cancer (CRC) has not been fully elucidated. Our intention was to investigate their role and identify their prognostic significance.METHODS: The IL-6, TNFα and CRP levels were measured in 74 CRC patients and the relationships between their elevations and both the clinicopathological factors and prognosis of patients were investigated. Serum concentrations of human IL-6 and TNFα were determined by enzyme-linked immunosorbent assay (ELISA). CRP was measured by an immunoturbinometric method. RESULTS: Median IL-6, TNFα and CRP levels were significantly higher in CRC patients than in normal controls. High levels of serum IL-6, TNFα and CRP were correlated with larger tumor size. Furthermore, high IL-6 and high CRP levels were associated with reduced overall survival. CONCLUSION: Serum IL-6, TNFα and CRP levels definitely increase in CRC patients. Pre-operative serum elevation of IL-6 and CRP was thus found to be predictor of the prognosis of CRC patients. The clinical value of TNFα in CRC needs to be further investigated.
|
| 关 键 词： | CRP IL-6 TNFα CRC ELISA |
| 收稿时间： | 2004-08-13 |
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications |
| |
| Nikiteas Nikolaos I,Tzanakis Nikolaos,Gazouli Maria,Rallis George,Daniilidis Kessaris,Theodoropoulos George,Kostakis Alkiviadis,Peros George. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications[J]. World journal of gastroenterology : WJG, 2005, 11(11): 1639-1643. DOI: 10.3748/wjg.v11.i11.1639 |
| |
| Authors: | Nikiteas Nikolaos I Tzanakis Nikolaos Gazouli Maria Rallis George Daniilidis Kessaris Theodoropoulos George Kostakis Alkiviadis Peros George |
| |
| Affiliation: | 2nd Propedeutic Department of Surgery, School of Medicine, University of Athens, Athens 11527, Greece. nnkit@med.uoa.gr |
| |
| Abstract: | AIM: The significance of preoperative serum IL-6, TNFalpha and CRP levels in the progression of colorectal cancer (CRC) has not been fully elucidated. Our intention was to investigate their role and identify their prognostic significance. METHODS: The IL-6, TNFalpha and CRP levels were measured in 74 CRC patients and the relationships between their elevations and both the clinicopathological factors and prognosis of patients were investigated. Serum concentrations of human IL-6 and TNFalpha were determined by enzyme-linked immunosorbent assay (ELISA). CRP was measured by an immunoturbinometric method. RESULTS: Median IL-6, TNFalpha and CRP levels were significantly higher in CRC patients than in normal controls. High levels of serum IL-6, TNFalpha and CRP were correlated with larger tumor size. Furthermore, high IL-6 and high CRP levels were associated with reduced overall survival. CONCLUSION: Serum IL-6, TNFalpha and CRP levels definitely increase in CRC patients. Pre-operative serum elevation of IL-6 and CRP was thus found to be predictor of the prognosis of CRC patients. The clinical value of TNFalpha in CRC needs to be further investigated. |
| |
| Keywords: | IL-6 TNFα CRP Colorectal cancer |
| 本文献已被 维普 PubMed 等数据库收录！ |
|
